Trial intelligence / Profile preview

Ketamine for Hemodynamic Stability in Cesarean Delivery

NCT05865080Completed

Sponsor
Al-Azhar University
Start
Jul 2022
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ketamine in hypotension (2 arms), sponsored by Al-Azhar University. Primary endpoint: Hemodynamic Stability. Started Jul 2022; status: completed.

02

Drugs

ketamine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT05865080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05865080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call